P430: MOLECULAR CHARACTERIZATION OF CLINICAL RESPONSE IN NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000844608.72364.51 |
| _version_ | 1797287866667106304 |
|---|---|
| author | S. de Botton S. Choe D. Marchione P. Montesinos C. Recher S. Vives Polo E. Zarzycka J. Wang G. Bertani M. Heuser R. Calado A. Schuh S.-P. Yeh J. Hui S. Pandya D. Gianolio S. Daigle C. DiNardo H. Dohner |
| author_facet | S. de Botton S. Choe D. Marchione P. Montesinos C. Recher S. Vives Polo E. Zarzycka J. Wang G. Bertani M. Heuser R. Calado A. Schuh S.-P. Yeh J. Hui S. Pandya D. Gianolio S. Daigle C. DiNardo H. Dohner |
| author_sort | S. de Botton |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:40:55Z |
| format | Article |
| id | doaj.art-e0f3eaa1e5d84f499c1eab8f841e79b0 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:40:55Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-e0f3eaa1e5d84f499c1eab8f841e79b02024-03-02T03:51:57ZengWileyHemaSphere2572-92412022-06-01633033110.1097/01.HS9.0000844608.72364.51202206003-00330P430: MOLECULAR CHARACTERIZATION OF CLINICAL RESPONSE IN NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINES. de Botton0S. Choe1D. Marchione2P. Montesinos3C. Recher4S. Vives Polo5E. Zarzycka6J. Wang7G. Bertani8M. Heuser9R. Calado10A. Schuh11S.-P. Yeh12J. Hui13S. Pandya14D. Gianolio15S. Daigle16C. DiNardo17H. Dohner181 Institut Gustave Roussy, Villejuif, France2 Servier Pharmaceuticals LLC, Boston, United States of America2 Servier Pharmaceuticals LLC, Boston, United States of America3 Hospital Universitari i Politècnic La Fe, València, Spain4 Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France5 Hospital Universitario Germans Trias i Pujol-ICO Badalona, Josep Carreras Research Institute, Badalona, Spain6 Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland7 Institute of Hematology & Hospital of Blood Disease, Tianjin, China8 ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy9 Hannover Medical School, Hannover, Germany10 Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil11 Princess Margaret Cancer Centre, Toronto, Canada12 China Medical University, Taichung, Taiwan2 Servier Pharmaceuticals LLC, Boston, United States of America2 Servier Pharmaceuticals LLC, Boston, United States of America2 Servier Pharmaceuticals LLC, Boston, United States of America2 Servier Pharmaceuticals LLC, Boston, United States of America13 The University of Texas M.D. Anderson Cancer Center, Houston, United States of America14 Ulm University Hospital, Ulm, Germanyhttp://journals.lww.com/10.1097/01.HS9.0000844608.72364.51 |
| spellingShingle | S. de Botton S. Choe D. Marchione P. Montesinos C. Recher S. Vives Polo E. Zarzycka J. Wang G. Bertani M. Heuser R. Calado A. Schuh S.-P. Yeh J. Hui S. Pandya D. Gianolio S. Daigle C. DiNardo H. Dohner P430: MOLECULAR CHARACTERIZATION OF CLINICAL RESPONSE IN NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE HemaSphere |
| title | P430: MOLECULAR CHARACTERIZATION OF CLINICAL RESPONSE IN NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE |
| title_full | P430: MOLECULAR CHARACTERIZATION OF CLINICAL RESPONSE IN NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE |
| title_fullStr | P430: MOLECULAR CHARACTERIZATION OF CLINICAL RESPONSE IN NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE |
| title_full_unstemmed | P430: MOLECULAR CHARACTERIZATION OF CLINICAL RESPONSE IN NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE |
| title_short | P430: MOLECULAR CHARACTERIZATION OF CLINICAL RESPONSE IN NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE |
| title_sort | p430 molecular characterization of clinical response in newly diagnosed acute myeloid leukemia patients treated with ivosidenib azacitidine compared to placebo azacitidine |
| url | http://journals.lww.com/10.1097/01.HS9.0000844608.72364.51 |
| work_keys_str_mv | AT sdebotton p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT schoe p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT dmarchione p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT pmontesinos p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT crecher p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT svivespolo p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT ezarzycka p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT jwang p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT gbertani p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT mheuser p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT rcalado p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT aschuh p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT spyeh p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT jhui p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT spandya p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT dgianolio p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT sdaigle p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT cdinardo p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT hdohner p430molecularcharacterizationofclinicalresponseinnewlydiagnosedacutemyeloidleukemiapatientstreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine |